On May 26, 2021 Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, reported that management will present at three upcoming virtual investor conferences in June (Press release, Evelo Biosciences, MAY 26, 2021, View Source [SID1234580598]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual Healthcare Conference. Management will host a presentation at 1:30 p.m. ET on Wednesday, June 2, 2021.

JMP Securities Life Sciences Conference. Management will host a fireside chat at 1:00 p.m. ET on Wednesday, June 16, 2021.

Raymond James Human Health Innovation Conference. Management will host a presentation at 9:20 a.m. ET on Tuesday, June 22, 2021.

Live audio webcasts of the presentations will be available on the Investors section of the Evelo website at View Source A replay of these webcasts will be available for approximately 30 days following each presentation.

On May 26, 2021 Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), reported that the Company will participate in the following upcoming investor conferences (Press release, Arbutus Biopharma, MAY 26, 2021, View Source [SID1234580597]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual Healthcare Conference

Wednesday, June 2, 2021 at 9:00 am ET (Fireside Chat)
Presenters: William Collier, President and Chief Executive Officer; Dr. Michael Sofia, Chief Scientific Officer; Dr. Gaston Picchio, Chief Development Officer; and David Hastings, Chief Financial Officer
Webcast Link
JMP Securities Life Sciences Conference – Virtual

Thursday, June 17, 2021 at 11:00 am ET (Fireside Chat)
Presenters: William Collier; Dr. Michael Sofia; Dr. Gaston Picchio; and David Hastings
Webcast Link
The webcast links for the virtual fireside chats can also be accessed through the Investors section of Arbutus’ website at www.arbutusbio.com. An archived replay of the webcast will be available on the Company’s website after the conference.

On May 26, 2021 Leidos (NYSE: LDOS), a FORTUNE 500 science and technology company, reported that it will participate in the Bernstein 37th Annual Strategic Decisions Conference webcast (Press release, Leidos, MAY 26, 2021, View Source [SID1234580596]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Roger Krone, Chief Executive Officer, will participate in a question and answer "fireside chat" on Wednesday, June 2, 2021 at 1:30 p.m. ET.

A live audio webcast of the event will be available on the Leidos Investor Relations website at View Source A replay of the webcast will be available following the presentation at the same link listed above for one year afterward.

On May 26, 2021 Bristol Myers Squibb (NYSE: BMY) reported that the company will participate in a fireside chat at Bernstein’s 37th Annual Strategic Decisions Virtual Conference, which will be webcast on Wednesday, June 2, 2021 (Press release, Bristol-Myers Squibb, MAY 26, 2021, View Source [SID1234580595]). Giovanni Caforio, M.D., Board Chair and Chief Executive Officer, will answer questions about the company at 10 a.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and the general public are invited to listen to a live webcast of the session at View Source An archived edition of the session will be available later that day.

On May 26, 2021 Invectys reported that it will be participating in the online 2021 ASCO (Free ASCO Whitepaper) Annual Meeting (Press release, Invectys, MAY 26, 2021, View Source [SID1234580594]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Although online, this landmark event will feature its trademark educational and scientific sessions, breakthrough announcements and networking opportunities.